GGrantIndex
← Leaderboards

James W Lillard

Morehouse School Of Medicine

$4,925,420
Attributed
$5,036,835
Total exposure
14
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.3M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,687,933 · 18

By mechanism

U54$19,411,108 · 8
R01$1,120,642 · 1
G12$964,873 · 4
R41$684,624 · 3
R43$294,331 · 1
R03$212,355 · 1

Top collaborators

Most similar at Morehouse School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Morehouse School Of Medicine

Research focus

Morehouse School Of MedicineResearch PersonnelInstitutionUniversitiesOutreachResearch Project GrantsComprehensive Cancer CenterProgramsResource SharingBioethicsAlabamaMalignant NeoplasmsCancer Health DisparityRacial And EthnicEnsureBaseAfrican AmericanEthicsPostdoctoral FellowMemberHealth DisparityFacultySuccessPilot Projects

Grant awards (54)

Personalized Outreach and Multifaceted Interventions for Screening Enhancement (PROMISE) for Anal and Cervical Cancer Prevention and Treatment$2,336,229
U54 · FY2025 · CA
Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership$1,101,911
U54 · FY2020 · CA · contact PI
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership$851,603
U54 · FY2020 · CA
Admin Core$356,283
U54 · FY2020 · CA · contact PI
MULTI-OMICS APPROACH ON NIGERIAN MEN WITH PROSTATE CANCER$199,302
U54 · FY2020 · CA
Bioethics Shared Resource$7,668
U54 · FY2020 · CA · contact PI
Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership$1,068,765
U54 · FY2019 · CA · contact PI
Detection of HIV proteins in urine to diagnose infection$296,230
R41 · FY2019 · MH · contact PI
Admin Core$237,662
U54 · FY2019 · CA · contact PI
Bioethics Shared Resource$6,325
U54 · FY2019 · CA · contact PI
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership$1
U54 · FY2019 · CA
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership$1,101,004
U54 · FY2018 · CA
Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership$1,090,193
U54 · FY2018 · CA · contact PI
Admin Core$229,354
U54 · FY2018 · CA · contact PI
CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer$101,078
U54 · FY2018 · CA · contact PI
Bioethics Shared Resource$2,737
U54 · FY2018 · CA · contact PI
Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership$1,117,456
U54 · FY2017 · CA · contact PI
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership$407,680
U54 · FY2017 · CA
Admin Core$231,730
U54 · FY2017 · CA · contact PI
CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer$104,228
U54 · FY2017 · CA · contact PI
Bioethics Shared Resource$6,481
U54 · FY2017 · CA · contact PI
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership$1,337,658
U54 · FY2016 · CA
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership$1,274,218
U54 · FY2016 · CA
Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership$1,009,450
U54 · FY2016 · CA · contact PI
Admin Core$209,333
U54 · FY2016 · CA · contact PI
Admin supplement$167,122
U54 · FY2016 · CA
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership$162,279
U54 · FY2016 · CA
CD24-dependent Inactivation of Mutant p53 in Metastatic Castration-resistant Prostate Cancer$94,154
U54 · FY2016 · CA · contact PI
Bioethics Shared Resource$5,855
U54 · FY2016 · CA · contact PI
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership$754,413
U54 · FY2015 · CA · contact PI
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership$881,384
U54 · FY2014 · CA · contact PI
Novel pharmacogenomic approach for identifying T cell epitopes in replacement FVI$203,849
R41 · FY2014 · MD · contact PI
Treatment of Colitis using a Novel CXCR3 Biologic Antagonist$97,160
R43 · FY2014 · DK · contact PI
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership$54,531
U54 · FY2014 · CA · contact PI
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership$660,287
U54 · FY2013 · CA · contact PI
Treatment of Colitis using a Novel CXCR3 Biologic Antagonist$197,171
R43 · FY2013 · DK · contact PI
Evaluation of the Antigenicity of Black Restricted FVIII Haplotypes and Haplotype$184,545
R41 · FY2013 · MD · contact PI
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership$56,218
U54 · FY2013 · CA · contact PI
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership$1,068,260
U54 · FY2012 · CA · contact PI
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership$50,000
U54 · FY2012 · CA · contact PI
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership$1,068,256
U54 · FY2011 · CA · contact PI
CELLS AND TISSUES$261,069
G12 · FY2011 · RR · contact PI
CELLS AND TISSUES$241,666
G12 · FY2010 · RR · contact PI
Role of RANTES in Pneumococcal Immunopathogenesis$245,578
R01 · FY2007 · AI · contact PI
Role of RANTES in Pneumococcal Immunopathogenesis$252,913
R01 · FY2006 · AI · contact PI
ROLE OF CHEMOKINES IN MUCOSAL IMMUNITY: ORAL, RESPIRATORY & UROGENITAL PATHOGENS$157,770
G12 · FY2006 · RR · contact PI
Role of RANTES in Pneumococcal Immunopathogenesis$1
R01 · FY2006 · AI · contact PI
Role of RANTES in Pneumococcal Immunopathogenesis$323,500
R01 · FY2005 · AI
ROLE OF CHEMOKINES IN MUCOSAL IMMUNITY: ORAL, RESPIRATORY &UROGENITAL PATHOGENS$119,611
G12 · FY2005 · RR
Role of RANTES in Pneumococcal Immunopathogenesis$298,650
R01 · FY2004 · AI
ROLE OF CHEMOKINES IN MUCOSAL IMMUNITY: ORAL, RESPIRATORY &UROGENITAL PATHOGENS$184,757
G12 · FY2004 · RR
ROLE OF CHEMOKINES IN T CELL MEDIATED COLITIS$70,785
R03 · FY2002 · DK
ROLE OF CHEMOKINES IN T CELL MEDIATED COLITIS$70,785
R03 · FY2001 · DK
ROLE OF CHEMOKINES IN T CELL MEDIATED COLITIS$70,785
R03 · FY2000 · DK